News
Could these old drugs help fight COVID-19 and save lives?
September 9, 2020
“The beauty of a repurposed drug is that if you can get funding and start enrolling patients, you could potentially find out fairly quickly, as early as a few months, if that drug has an antiviral effect or not.”
![1]()
News
MIS-C cardiac evaluation requires more than EF
September 9, 2020
Children with COVID-19 and multisystem inflammatory syndrome need a thorough coronary work-up to evaluate later-phase cardiac injury and dysfunction.
News
Unexpected results in new COVID-19 ‘cytokine storm’ data
September 9, 2020
Circulating cytokine concentrations are lower in patients with COVID-19, compared with other diseases.
![1]()
News
HM20 Virtual: Improved supervision of residents
September 9, 2020
Resident supervision is driven by three factors: what residents need, what residents want, and what the supervisor can provide.
News
HHS plan to improve rural health focuses on better broadband, telehealth services
September 8, 2020
The announcement includes technical initiatives, such as a contract to help clinics and hospitals integrate care.
![1]()
News
Study: 10% of pregnant women test positive for COVID-19, with most asymptomatic
September 8, 2020
This study is based on ongoing living systematic reviews of the literature, in which information is posted in real time on the website.
![1]()
News
PHM20 Virtual: Impact of racism in medicine
September 8, 2020
The field of pediatric hospital medicine must recognize the role that race plays in propagating inequalities.
![1]()
News
Asymptomatic children may transmit COVID-19 in communities
September 3, 2020
A South Korean case series of 91 children with COVID-19 identified detectable viral RNA for approximately 2 weeks’ duration.
![1]()
News
Statins linked to reduced mortality in COVID-19
September 3, 2020
A pooled analysis of available data suggest moderate- to high-intensity statin therapy may be beneficial in patients with COVID-19, researchers said.
![1]()
News
Minidose edoxaban may safely cut AFib stroke risk in the frail, very elderly
September 3, 2020
Those who took the factor Xa inhibitor edoxaban (Savaysa) at the off-label dosage of 15 mg once daily showed a two-thirds drop in risk for stroke or systemic embolism, compared with patients who received placebo.
